Market Survey on Peri-implantitis Treatment Market Covering Sales Outlook, Up-to-date Key Trends, Market Size and Forecast, Per Capita Expenditure, Company Share, Brand Share, Regulations, Reimbursement Scenario, Epidemiology, Procedure Numbers, and Pipeline Assessment
An In-depth Market Insights of Peri-implantitis Treatment Market including Surgical Treatment of Peri-Implantitis, and Non-Surgical Treatment of Peri-Implantitis Covering 30+ Countries like United States, United Kingdom, Germany, France, Norway, Sweden, Saudi Arabia, United Arab Emirates, Japan, Korea, Australia, New Zealand, and Others
Peri-Implantitis Treatment Market Snapshot (2022 to 2032)
The global peri-implantitis treatment market is anticipated to be valued at US$ 2.3 Billion in 2022, forecast to grow at a CAGR of 8.7% to be valued at US$ 4.5 Billion from 2022 to 2032. Growth is attributed to the rising usage of dental implants for prosthetic rehabilitation. From 2021 to 2022, a Y-o-Y growth rate of 4.5% is expected for the market, inclining from its previous valuation of US$ 2.2 Billion in 2021.
Report Attribute
Details
Estimated Base Year Value (2021)
US$ 2.2 Billion
Expected Market Value (2022)
US$ 2.3 Billion
Anticipated Forecast Value (2032)
US$ 4.5 Billion
Projected Growth Rate (2022 to 2032)
8.7% CAGR
Dental implants have turned into an established therapy in dentistry essential to replace missing teeth in different clinical situations. Peri-implantitis is a site-specific infectious disease, that affects the soft and hard tissue surrounding a dental implant. Peri-Implantitis is an inflammatory reaction with the loss of a supporting bone in the tissues surrounding a dental implant.
According to the National Center for Biotechnology Information (NCBI), over an average follow-up of 2 years in the USA, the prevalence of peri-implantitis was 34.0% on the patient level and 21% on the implant level. The rising demand for dental implants is a major factor that contributes to the growth of the market for peri-implantitis. However, the lack of awareness regarding the treatment is a major factor that hampers the market growth during the forecast period. People having a history of periodontal disease are more susceptible to peri-implantitis.
According to the Centers for Disease Control and Prevention (CDC), in 2019, 47.2% of adults aged 30 years in the USA had some form of periodontal disease, with the condition being more common in men than women, as they are more prone to smoking and health conditions like diabetes.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Which are Some Prominent Drivers Spearheading Peri-implantitis Treatment Market Growth?
The rising usage of dental implants for prosthetic rehabilitation is one of the major factors that is expected to accelerate the global peri-implantitis market during the forecast period. Growing public knowledge about oral hygiene has resulted in an increase in dental visits, which in turn is likely to boost the demand for the peri-implantitis treatment market.
Moreover, the aging population is likely to play a significant role in fueling the demand for peri-implantitis treatment over the analysis period. Technological advancements have resulted in several dental methods such as dental grafting, which are expected to present lucrative opportunities for market players in the peri-implantitis market.
Increased tobacco use and smoking rates cause a variety of oral disorders, which are expected to further increase the growth for peri-implantitis treatment during the forecast period.
Additionally, the rising demand for anti-aging treatments and procedures such as wrinkles, age spots, and other procedures is expected to propel the market growth during the forecast period, owing to the growing elderly population. Furthermore, advanced microdermabrasion devices are likely to expand in popularity among consumers, which would boost market expansion over the analysis period.
What are the Challenges Faced by the Peri-implantitis Treatment Industry?
The high cost of dental implants is one of the major factors that is expected to impede the growth of the peri-implantitis treatment market during the forecast period. In addition, a lack of skilled dental specialties can restrain the peri-implantitis treatment market.
In addition, the other major setback for the market’s growth is that bone loss is only apparent in radiographs when 30% of the bone mass is lost, which can make early detection difficult. This in turn is expected to restrain market growth.
Moreover, lack of awareness regarding the treatment is a major factor that hampers the peri-implantitis market in developing countries.
Find your sweet spots for generating winning opportunities in this market.
Why is North America Emerging as an Opportunistic Peri-implantitis Treatment Market?
The peri-implantitis market in North America is expected to hold the largest share of US$ 719 Million, attributed to the availability of high healthcare expenditure. The regional market is expected to reach a CAGR of 8.3% during the forecast period.
Factors such as the growing burden of dental diseases and well-developed healthcare facilities in the region are also expected to augment the market’s growth over the analysis period.
Additionally, the market in the region is expected to propel, owing to the rise in the geriatric population, increasing initiatives by the market players for technological advancements in peri-implantitis devices, and a highly aware population in the region.
How is Asia-Pacific Contributing to Growth of the Peri-implantitis Treatment Market?
The Asia-Pacific is expected to register the fastest growth in revenue generation for the peri-implantitis treatment market due to the large population in countries such as China, and India.
On the other hand, factors such as the rising number of market players focusing on the launch of dental equipment in the region are expected to accelerate market growth.
The availability of developed healthcare facilities and favorable government initiatives in India, China, and Japan are the other major factors that will boost the market growth in the Asia-Pacific region, over the forecast period.
Populous countries like India and China suffer from a heavy burden of oral diseases and Dental Implants (DIs) are prescribed widely by dental practitioners to replace lost natural teeth and are gaining prominence. Moreover, India and China are currently the largest tobacco-producing and consuming countries having the lowest smoking awareness. These are the factors that are expected to fuel the market for peri-implantitis in the region. The Asia-Pacific peri-implantitis market is expected to reach a CAGR of 8.1%.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Market Competition
Some of the key participants present in the global Peri-implantitis Treatment market include Pfizer Inc., Cadila Pharmaceuticals, R.N. Laboratories Pvt. Ltd., Basic Pharma Life Science Pvt. Ltd., Prachi Pharmaceuticals Private Limited., Healthy Life Pharma Private Limited, Triveni chemicals, Geistlich Pharma, and Dawood & Tanner, among others.
Attributed to the presence of such a high number of participants, the market is highly competitive. While global players such as Pfizer Inc., Cadila Pharmaceuticals, and R.N. Laboratories Pvt. Ltd. account for a considerable market size, several regional-level players are also operating across key growth regions, particularly in the Asia Pacific.
Recent Developments:
In November 2020, Aspen Dental Management (ADMI) announced that it had signed an agreement with Sun Capital Partners, Inc. to acquire ClearChoice Management Services (CCMS), which provides comprehensive practice support services to the nationwide network of ClearChoice Dental Implant Centers.
In January 2019, OraCare announced the launch of an implant post-op care system. The new system is designed to prevent the development of peri-implantitis by targeting the specific microorganisms and compounds known to cause the complication.
Report Scope
Report Attribute
Details
Growth Rate
CAGR of 7% from 2022 to 2032
Market Value in 2022
US$ 2.3 Billion
Market Value in 2032
US$ 4.5 Billion
Base Year for Estimation
2021
Historical Data
2017 to 2021
Forecast Period
2022 to 2032
Quantitative Units
Revenue in USD Billion, Volume in Kilotons, and CAGR from 2022 to 2032
Report Coverage
Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segments Covered
Method Type
End-User
Region
Regional Scope
North America
Latin America
Europe
Asia Pacific
Middle East and Africa
Country Scope
USA
Canada
Mexico
Brazil
Germany
United Kingdom
France
Spain
Italy
China
Japan
South Korea
Malaysia
Singapore
Australia
GCC Countries
South Africa
Israel
Key Companies Profiled
Pfizer Inc.
Cadila Pharmaceuticals
R N. Laboratories
Triveni Chemicals
Basic Pharma Life Sciences
Prachi Pharmaceuticals
Healthy Life Pharma Private Limited
Pricing and Purchase Options
Avail customized purchase options to meet your exact research needs.
Key Segments Profiled in the Peri-implantitis Treatment Industry Survey
Peri-Implantitis Treatment Market by Method Type:
Surgical Treatment of Peri-Implantitis
Mechanical Debridement
Laser Debridement
Open Flap Debridement
Open Flap Debridement with Guided Bone Generation
Non-Surgical Treatment of Peri-Implantitis
Surface Debridement
Antibiotics (Chlorhexidine Digluconate)
Others
Peri-Implantitis Treatment Market by End-User:
Peri-Implantitis Treatment in Hospitals
Peri-Implantitis Treatment in Dental Clinics
Peri-implantitis Treatment Market by Region:
North America Peri-Implantitis Treatment Market
Latin America Peri-Implantitis Treatment Market
Europe Peri-Implantitis Treatment Market
Asia Pacific Peri-Implantitis Treatment Market
Middle East & Africa Peri-Implantitis Treatment Market
Frequently Asked Questions
What is the anticipated growth of the Peri-implantitis Treatment market until 2032?
FMI projects the global Peri-implantitis Treatment market to expand at a 7% value CAGR by 2032
Which region is forecast to be the most lucrative for Peri-implantitis Treatment market growth?
Asia Pacific is expected to be the most opportunistic Peri-implantitis Treatment market, expanding at 8.1% CAGR
Which are some prominent Peri-implantitis Treatment manufacturers?
Pfizer Inc., Cadila Pharmaceuticals, R.N. Laboratories Pvt. Ltd., and Basic Pharma Life Science Pvt. Ltd. are some prominent Peri-implantitis Treatment manufacturers
Table of Content
1. Executive Summary | Peri-implantitis Treatment Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032
4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021
4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Method Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Method Type, 2017 to 2021
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Method Type, 2022 to 2032
5.3.1. Surgical Treatment
5.3.1.1. Mechanical Debridement
5.3.1.2. Laser Debridement
5.3.1.3. Open Flap Debridement
5.3.1.4. Open Flap Debridement with guided bone generation
5.3.2. Non-Surgical Treatment
5.3.2.1. Surface Debridement
5.3.2.2. Antibiotics ( Chlorhexidine Digluconate )
5.3.2.3. Others
5.4. Y-o-Y Growth Trend Analysis By Method Type, 2017 to 2021
5.5. Absolute $ Opportunity Analysis By Method Type, 2022 to 2032
6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2017 to 2021
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2022 to 2032
6.3.1. Hospitals
6.3.2. Dental Clinics
6.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2021
6.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032
7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021
7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
8.2.1. By Country
8.2.1.1. USA
8.2.1.2. Canada
8.2.2. By Method Type
8.2.3. By End User
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Method Type
8.3.3. By End User
8.4. Key Takeaways
9. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Method Type
9.2.3. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Method Type
9.3.3. By End User
9.4. Key Takeaways
10. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. United Kingdom
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Europe
10.2.2. By Method Type
10.2.3. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Method Type
10.3.3. By End User
10.4. Key Takeaways
11. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.1.4. Malaysia
11.2.1.5. Singapore
11.2.1.6. Australia
11.2.1.7. Rest of Asia Pacific
11.2.2. By Method Type
11.2.3. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Method Type
11.3.3. By End User
11.4. Key Takeaways
12. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
12.2.1. By Country
12.2.1.1. GCC Countries
12.2.1.2. South Africa
12.2.1.3. Israel
12.2.1.4. Rest of Middle East and Africa
12.2.2. By Method Type
12.2.3. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Method Type
12.3.3. By End User
12.4. Key Takeaways
13. Key Countries Market Analysis
13.1. USA
13.1.1. Pricing Analysis
13.1.2. Market Share Analysis, 2021
13.1.2.1. By Method Type
13.1.2.2. By End User
13.2. Canada
13.2.1. Pricing Analysis
13.2.2. Market Share Analysis, 2021
13.2.2.1. By Method Type
13.2.2.2. By End User
13.3. Brazil
13.3.1. Pricing Analysis
13.3.2. Market Share Analysis, 2021
13.3.2.1. By Method Type
13.3.2.2. By End User
13.4. Mexico
13.4.1. Pricing Analysis
13.4.2. Market Share Analysis, 2021
13.4.2.1. By Method Type
13.4.2.2. By End User
13.5. Rest of Latin America
13.5.1. Pricing Analysis
13.5.2. Market Share Analysis, 2021
13.5.2.1. By Method Type
13.5.2.2. By End User
13.6. Germany
13.6.1. Pricing Analysis
13.6.2. Market Share Analysis, 2021
13.6.2.1. By Method Type
13.6.2.2. By End User
13.7. United Kingdom
13.7.1. Pricing Analysis
13.7.2. Market Share Analysis, 2021
13.7.2.1. By Method Type
13.7.2.2. By End User
13.8. France
13.8.1. Pricing Analysis
13.8.2. Market Share Analysis, 2021
13.8.2.1. By Method Type
13.8.2.2. By End User
13.9. Spain
13.9.1. Pricing Analysis
13.9.2. Market Share Analysis, 2021
13.9.2.1. By Method Type
13.9.2.2. By End User
13.10. Italy
13.10.1. Pricing Analysis
13.10.2. Market Share Analysis, 2021
13.10.2.1. By Method Type
13.10.2.2. By End User
13.11. Rest of Europe
13.11.1. Pricing Analysis
13.11.2. Market Share Analysis, 2021
13.11.2.1. By Method Type
13.11.2.2. By End User
13.12. China
13.12.1. Pricing Analysis
13.12.2. Market Share Analysis, 2021
13.12.2.1. By Method Type
13.12.2.2. By End User
13.13. Japan
13.13.1. Pricing Analysis
13.13.2. Market Share Analysis, 2021
13.13.2.1. By Method Type
13.13.2.2. By End User
13.14. South Korea
13.14.1. Pricing Analysis
13.14.2. Market Share Analysis, 2021
13.14.2.1. By Method Type
13.14.2.2. By End User
13.15. Malaysia
13.15.1. Pricing Analysis
13.15.2. Market Share Analysis, 2021
13.15.2.1. By Method Type
13.15.2.2. By End User
13.16. Singapore
13.16.1. Pricing Analysis
13.16.2. Market Share Analysis, 2021
13.16.2.1. By Method Type
13.16.2.2. By End User
13.17. Australia
13.17.1. Pricing Analysis
13.17.2. Market Share Analysis, 2021
13.17.2.1. By Method Type
13.17.2.2. By End User
13.18. Rest of Asia Pacific
13.18.1. Pricing Analysis
13.18.2. Market Share Analysis, 2021
13.18.2.1. By Method Type
13.18.2.2. By End User
13.19. GCC Countries
13.19.1. Pricing Analysis
13.19.2. Market Share Analysis, 2021
13.19.2.1. By Method Type
13.19.2.2. By End User
13.20. South Africa
13.20.1. Pricing Analysis
13.20.2. Market Share Analysis, 2021
13.20.2.1. By Method Type
13.20.2.2. By End User
13.21. Israel
13.21.1. Pricing Analysis
13.21.2. Market Share Analysis, 2021
13.21.2.1. By Method Type
13.21.2.2. By End User
13.22. Rest of the Middle East and Africa
13.22.1. Pricing Analysis
13.22.2. Market Share Analysis, 2021
13.22.2.1. By Method Type
13.22.2.2. By End User
14. Market Structure Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Market Share Analysis of Top Players
14.3.1. By Regional
14.3.2. By Method Type
14.3.3. By End User
15. Competition Analysis
15.1. Competition Deep Dive
15.1.1. Pfizer Inc.
15.1.1.1. Overview
15.1.1.2. Product Portfolio
15.1.1.3. Profitability by Market Segments
15.1.1.4. Sales Footprint
15.1.1.5. Strategy Overview
15.1.1.5.1. Marketing Strategy
15.1.2. Cadila Pharmaceuticals
15.1.2.1. Overview
15.1.2.2. Product Portfolio
15.1.2.3. Profitability by Market Segments
15.1.2.4. Sales Footprint
15.1.2.5. Strategy Overview
15.1.2.5.1. Marketing Strategy
15.1.3. R.N. Laboratories Pvt. Ltd.
15.1.3.1. Overview
15.1.3.2. Product Portfolio
15.1.3.3. Profitability by Market Segments
15.1.3.4. Sales Footprint
15.1.3.5. Strategy Overview
15.1.3.5.1. Marketing Strategy
15.1.4. Basic Pharma Life Science Pvt. Ltd.
15.1.4.1. Overview
15.1.4.2. Product Portfolio
15.1.4.3. Profitability by Market Segments
15.1.4.4. Sales Footprint
15.1.4.5. Strategy Overview
15.1.4.5.1. Marketing Strategy
15.1.5. Prachi Pharmaceuticals Private Limited.
15.1.5.1. Overview
15.1.5.2. Product Portfolio
15.1.5.3. Profitability by Market Segments
15.1.5.4. Sales Footprint
15.1.5.5. Strategy Overview
15.1.5.5.1. Marketing Strategy
15.1.6. Healthy Life Pharma Private Limited
15.1.6.1. Overview
15.1.6.2. Product Portfolio
15.1.6.3. Profitability by Market Segments
15.1.6.4. Sales Footprint
15.1.6.5. Strategy Overview
15.1.6.5.1. Marketing Strategy
15.1.7. Triveni Chemicals
15.1.7.1. Overview
15.1.7.2. Product Portfolio
15.1.7.3. Profitability by Market Segments
15.1.7.4. Sales Footprint
15.1.7.5. Strategy Overview
15.1.7.5.1. Marketing Strategy
16. Assumptions & Acronyms Used17. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2017 to 2032
Table 2: Global Market Value (US$ Million) Forecast by Method Type, 2017 to 2032
Table 3: Global Market Value (US$ Million) Forecast by End User, 2017 to 2032
Table 4: North America Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 5: North America Market Value (US$ Million) Forecast by Method Type, 2017 to 2032
Table 6: North America Market Value (US$ Million) Forecast by End User, 2017 to 2032
Table 7: Latin America Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 8: Latin America Market Value (US$ Million) Forecast by Method Type, 2017 to 2032
Table 9: Latin America Market Value (US$ Million) Forecast by End User, 2017 to 2032
Table 10: Europe Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 11: Europe Market Value (US$ Million) Forecast by Method Type, 2017 to 2032
Table 12: Europe Market Value (US$ Million) Forecast by End User, 2017 to 2032
Table 13: Asia Pacific Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 14: Asia Pacific Market Value (US$ Million) Forecast by Method Type, 2017 to 2032
Table 15: Asia Pacific Market Value (US$ Million) Forecast by End User, 2017 to 2032
Table 16: MEA Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 17: MEA Market Value (US$ Million) Forecast by Method Type, 2017 to 2032
Table 18: MEA Market Value (US$ Million) Forecast by End User, 2017 to 2032
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Million) by Method Type, 2022 to 2032
Figure 2: Global Market Value (US$ Million) by End User, 2022 to 2032
Figure 3: Global Market Value (US$ Million) by Region, 2022 to 2032
Figure 4: Global Market Value (US$ Million) Analysis by Region, 2017 to 2032
Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2022 to 2032
Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2022 to 2032
Figure 7: Global Market Value (US$ Million) Analysis by Method Type, 2017 to 2032
Figure 8: Global Market Value Share (%) and BPS Analysis by Method Type, 2022 to 2032
Figure 9: Global Market Y-o-Y Growth (%) Projections by Method Type, 2022 to 2032
Figure 10: Global Market Value (US$ Million) Analysis by End User, 2017 to 2032
Figure 11: Global Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 12: Global Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 13: Global Market Attractiveness by Method Type, 2022 to 2032
Figure 14: Global Market Attractiveness by End User, 2022 to 2032
Figure 15: Global Market Attractiveness by Region, 2022 to 2032
Figure 16: North America Market Value (US$ Million) by Method Type, 2022 to 2032
Figure 17: North America Market Value (US$ Million) by End User, 2022 to 2032
Figure 18: North America Market Value (US$ Million) by Country, 2022 to 2032
Figure 19: North America Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 22: North America Market Value (US$ Million) Analysis by Method Type, 2017 to 2032
Figure 23: North America Market Value Share (%) and BPS Analysis by Method Type, 2022 to 2032
Figure 24: North America Market Y-o-Y Growth (%) Projections by Method Type, 2022 to 2032
Figure 25: North America Market Value (US$ Million) Analysis by End User, 2017 to 2032
Figure 26: North America Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 27: North America Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 28: North America Market Attractiveness by Method Type, 2022 to 2032
Figure 29: North America Market Attractiveness by End User, 2022 to 2032
Figure 30: North America Market Attractiveness by Country, 2022 to 2032
Figure 31: Latin America Market Value (US$ Million) by Method Type, 2022 to 2032
Figure 32: Latin America Market Value (US$ Million) by End User, 2022 to 2032
Figure 33: Latin America Market Value (US$ Million) by Country, 2022 to 2032
Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 37: Latin America Market Value (US$ Million) Analysis by Method Type, 2017 to 2032
Figure 38: Latin America Market Value Share (%) and BPS Analysis by Method Type, 2022 to 2032
Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Method Type, 2022 to 2032
Figure 40: Latin America Market Value (US$ Million) Analysis by End User, 2017 to 2032
Figure 41: Latin America Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 42: Latin America Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 43: Latin America Market Attractiveness by Method Type, 2022 to 2032
Figure 44: Latin America Market Attractiveness by End User, 2022 to 2032
Figure 45: Latin America Market Attractiveness by Country, 2022 to 2032
Figure 46: Europe Market Value (US$ Million) by Method Type, 2022 to 2032
Figure 47: Europe Market Value (US$ Million) by End User, 2022 to 2032
Figure 48: Europe Market Value (US$ Million) by Country, 2022 to 2032
Figure 49: Europe Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 50: Europe Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 51: Europe Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 52: Europe Market Value (US$ Million) Analysis by Method Type, 2017 to 2032
Figure 53: Europe Market Value Share (%) and BPS Analysis by Method Type, 2022 to 2032
Figure 54: Europe Market Y-o-Y Growth (%) Projections by Method Type, 2022 to 2032
Figure 55: Europe Market Value (US$ Million) Analysis by End User, 2017 to 2032
Figure 56: Europe Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 57: Europe Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 58: Europe Market Attractiveness by Method Type, 2022 to 2032
Figure 59: Europe Market Attractiveness by End User, 2022 to 2032
Figure 60: Europe Market Attractiveness by Country, 2022 to 2032
Figure 61: Asia Pacific Market Value (US$ Million) by Method Type, 2022 to 2032
Figure 62: Asia Pacific Market Value (US$ Million) by End User, 2022 to 2032
Figure 63: Asia Pacific Market Value (US$ Million) by Country, 2022 to 2032
Figure 64: Asia Pacific Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 65: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 66: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 67: Asia Pacific Market Value (US$ Million) Analysis by Method Type, 2017 to 2032
Figure 68: Asia Pacific Market Value Share (%) and BPS Analysis by Method Type, 2022 to 2032
Figure 69: Asia Pacific Market Y-o-Y Growth (%) Projections by Method Type, 2022 to 2032
Figure 70: Asia Pacific Market Value (US$ Million) Analysis by End User, 2017 to 2032
Figure 71: Asia Pacific Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 72: Asia Pacific Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 73: Asia Pacific Market Attractiveness by Method Type, 2022 to 2032
Figure 74: Asia Pacific Market Attractiveness by End User, 2022 to 2032
Figure 75: Asia Pacific Market Attractiveness by Country, 2022 to 2032
Figure 76: MEA Market Value (US$ Million) by Method Type, 2022 to 2032
Figure 77: MEA Market Value (US$ Million) by End User, 2022 to 2032
Figure 78: MEA Market Value (US$ Million) by Country, 2022 to 2032
Figure 79: MEA Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 80: MEA Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 81: MEA Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 82: MEA Market Value (US$ Million) Analysis by Method Type, 2017 to 2032
Figure 83: MEA Market Value Share (%) and BPS Analysis by Method Type, 2022 to 2032
Figure 84: MEA Market Y-o-Y Growth (%) Projections by Method Type, 2022 to 2032
Figure 85: MEA Market Value (US$ Million) Analysis by End User, 2017 to 2032
Figure 86: MEA Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 87: MEA Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 88: MEA Market Attractiveness by Method Type, 2022 to 2032
Figure 89: MEA Market Attractiveness by End User, 2022 to 2032
Figure 90: MEA Market Attractiveness by Country, 2022 to 2032
